See more : Klaviyo, Inc. (KVYO) Income Statement Analysis – Financial Results
Complete financial analysis of Sunniva Inc. (SNN.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sunniva Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Tungkong Inc. (002117.SZ) Income Statement Analysis – Financial Results
- Shinsei Bank, Limited (SKLKF) Income Statement Analysis – Financial Results
- izertis, S.A. (IZER.MC) Income Statement Analysis – Financial Results
- Alexander & Baldwin, Inc. (ALEX) Income Statement Analysis – Financial Results
- Savara Inc. (SVRA) Income Statement Analysis – Financial Results
Sunniva Inc. (SNN.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.sunniva.com
About Sunniva Inc.
Sunniva Inc., a vertically integrated cannabis company, focuses on the cultivation, production, and distribution of various therapeutic solutions in Canada and the United States. The company operates through Patient Counselling, Merchandising, and Cultivation & Extraction segments. It offers its products under the Sun Fire, Kyndness, and Herbella brands. The company was formerly known as Sunniva Holdings Corp. and changed its name to Sunniva Inc. in August 2017. Sunniva Inc. was founded in 2014 and is headquartered in Vancouver, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 18.79M | 16.07M | 38.00K |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 10.99M | 9.39M | 12.00K |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 7.80M | 6.68M | 26.00K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 41.51% | 41.58% | 68.42% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 110.00K | 314.00K |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 32.06M | 17.29M | 3.43M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 884.00K | 889.00K | 167.00K |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 32.95M | 18.18M | 3.60M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 2.93M | 2.53M | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 35.88M | 20.81M | 3.91M |
| Cost & Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 46.87M | 30.20M | 3.92M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 1.00K | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 953.00K | 186.00K | 54.00K |
| Depreciation & Amortization | 228.49K | 236.56K | 206.30K | 171.86K | 2.23M | 2.40M | 1.32M |
| EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | -25.47M | -16.66M | -4.72M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -137.58% | -72.99% | -12,407.89% |
| Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | -28.08M | -14.13M | -6.03M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -149.46% | -87.92% | -15,876.32% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -1.23M | -5.29M | -854.00K |
| Income Before Tax | 0.00 | 0.00 | 0.00 | 0.00 | -29.36M | -20.46M | -6.89M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -156.24% | -127.30% | -18,123.68% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | -308.00K | -1.99M | -1.26M |
| Net Income | 0.00 | 0.00 | 0.00 | 0.00 | -29.05M | -18.47M | -5.62M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -154.60% | -114.93% | -14,797.37% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.91 | -0.60 | -0.18 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.91 | -0.60 | -0.18 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 | 31.81M | 30.64M | 30.64M |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 | 31.81M | 30.64M | 30.64M |
Source: https://incomestatements.info
Category: Stock Reports